Autophagy sustains mitochondrial respiration and determines resistance to BRAFV600E inhibition in thyroid carcinoma

Sergio Díaz-Gago1, Javier Vicente-Gutiérrez1, Jose Manuel Ruiz-Rodríguez1

  • 1Universidad de Alcalá, Facultad de Medicina y Ciencias de la Salud, Departamento de Biología de Sistemas, Unidad de Bioquímica y Biología Molecular, Madrid, Spain.

Autophagy
|March 4, 2024
PubMed

Insights

Thyroid cancer cells rely on fatty acid oxidation for survival, regulated by autophagy. Inhibiting autophagy forces cells to use glycolysis, increasing sensitivity to vemurafenib, a BRAF inhibitor.

Area of Science:

  • Metabolic pathways in cancer
  • Molecular mechanisms of thyroid cancer
  • Autophagy and cancer therapeutics

Background:

  • BRAFV600E mutation is common in thyroid cancer, linked to poor outcomes and resistance to targeted therapies.
  • Advanced thyroid tumors like anaplastic thyroid carcinomas respond poorly to current BRAFV600E inhibitors.
  • Understanding alternative survival mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the metabolic dependencies of thyroid tumor cells for potential therapeutic exploitation.
  • To explore the role of autophagy in regulating fatty acid oxidation and cellular respiration.
  • To assess the impact of modulating autophagy and glycolysis on sensitivity to BRAFV600E inhibitors.

Main Methods:

  • Analysis of thyroid carcinoma cell respiration and its dependence on fatty acid oxidation (FAO).
  • Investigation of macroautophagy/autophagy's role in regulating mitochondrial fatty acid availability.
  • Assessment of cell survival and drug sensitivity following inhibition of autophagy, FAO, or glycolysis.

Main Results:

  • Thyroid carcinoma cell respiration is highly dependent on FAO, with mitochondrial fatty acid availability regulated by autophagy.
  • Inhibition of autophagy or lysosomal function enhances lipolysis, but this is not essential for cell survival.
  • Thyroid tumor cells compensate for impaired oxidative phosphorylation by increasing glycolysis; this glycolytic boost is essential for survival in autophagy-deficient cells and enhances sensitivity to vemurafenib.

Conclusions:

  • Autophagy plays a key role in thyroid cancer metabolism by regulating FAO.
  • Targeting glycolysis in combination with BRAFV600E inhibition offers a promising therapeutic strategy.
  • Mitochondrial targeting combined with vemurafenib may be effective for eliminating BRAFV600E-positive thyroid carcinoma cells.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.5K